PXMP2 Antibody

What is PXMP2 and what is its cellular localization?

PXMP2 (Peroxisomal Membrane Protein 2) is a 195 amino acid multi-pass membrane protein that belongs to the peroxisomal membrane protein PXMP2/4 family. Also known as PMP22, it is one of the most abundant peroxisomal membrane proteins in higher eukaryotes . PXMP2 is tissue-specifically expressed with highest levels in liver, kidney, and heart tissue . The gene maps to human chromosome 12q24.33 and has been conserved across multiple species .

Functionally, PXMP2 appears to be involved in pore-forming activity and contributes to the permeability characteristics of the peroxisomal membrane, facilitating metabolite transport between the peroxisomal matrix and cytosol .

What are the key applications for PXMP2 antibodies in research?

PXMP2 antibodies have several important research applications with specific protocol parameters:

When selecting a PXMP2 antibody, researchers should consider the specific epitope targeted (e.g., antibodies against amino acids 40-68 from the central region of human PXMP2 are common) and whether the application requires conjugated versions (FITC, PE, APC, HRP, or biotin) .

What is the molecular structure and weight of the PXMP2 protein?

PXMP2 is a 22 kDa protein with the following characteristics:

• Contains 195 amino acids in its full-length form

• Functions as a multi-pass membrane protein traversing the peroxisomal membrane multiple times

• Calculated molecular weight based on amino acid sequence: 22,253 Da

• Observed molecular weight in Western blot: approximately 22 kDa

• UniProt ID: Q9NR77 (Human)

• NCBI Gene ID: 5827

Interestingly, while PXMP2 functions as a channel-forming protein, protein data-based analysis reveals that PXMP2 family members share no sequence or structural similarities with known porin proteins or other channels , suggesting a unique structural arrangement for its pore-forming capabilities.

Which species show conservation of the PXMP2 gene?

PXMP2 is highly conserved across numerous species, indicating its evolutionary importance for peroxisomal function:

This extensive conservation suggests that PXMP2 serves a fundamental role in peroxisomal membrane function across diverse organisms . When selecting antibodies for cross-species studies, researchers should verify the specific reactivity claimed by manufacturers.

How do knockout models help elucidate PXMP2 function in peroxisomal permeability?

Knockout models have provided crucial insights into PXMP2's role in peroxisomal membrane permeability:

Studies with Pxmp2−/− mice have revealed that:

• Disruption of the mouse Pxmp2 gene leads to partial restriction of peroxisomal membrane permeability to solutes both in vitro and in vivo .

• Pxmp2−/− mice exhibit elevated levels of uric acid in blood compared to wild-type animals, with a concomitant decrease in allantoin excretion. This suggests the elevated uric acid results from decreased degradation rather than enhanced purine catabolism .

• Despite these metabolic changes, the "total" urate oxidase activity and protein content remain unchanged in liver homogenates of Pxmp2−/− mice, indicating that the observed effects are due to transport limitations rather than enzymatic deficiencies .

These findings demonstrate that PXMP2 functions as a channel-forming protein in the peroxisomal membrane that facilitates the movement of specific metabolites, although it is not the only protein responsible for peroxisomal membrane permeability .

What is the role of PXMP2 in hydrogen peroxide transport across the peroxisomal membrane?

Current evidence suggests PXMP2 may not be directly involved in hydrogen peroxide (H₂O₂) transport:

• Studies using gene deletion approaches: Single and double deletions of both PXMP2 and Pex11β genes were created in human HEK293 cells overexpressing D-amino acid oxidase (to induce elevated intraperoxisomal H₂O₂ levels) .

• Methodology: Intraperoxisomal H₂O₂ was measured in vivo using fluorescent H₂O₂ biosensors specifically targeted to peroxisomes .

• Results: Neither single nor double deletions led to any detectable change in the concentration of intraperoxisomal H₂O₂, strongly suggesting these proteins are not directly involved in H₂O₂ export .

• Additional finding: The results also indicate that PXMP2 and Pex11β are not required for the import of D-alanine, the substrate of D-amino acid oxidase .

While PXMP2 does function as a pore-forming protein facilitating the transport of certain metabolites, current experimental evidence does not support a role in H₂O₂ transport across the peroxisomal membrane .

How do PXMP2 protein-protein interactions contribute to its function?

PXMP2 engages in several protein-protein interactions that are important for its localization and function:

• Peroxin 19 (PEX19): PXMP2 interacts with PEX19, a protein that binds multiple peroxisomal membrane proteins (PMPs) . PEX19 is predominantly cytoplasmic and required for peroxisome membrane synthesis, suggesting its interaction with PXMP2 may be crucial for proper targeting or stabilization of PXMP2 at the peroxisomal membrane .

• Siva protein: PXMP2 has been reported to interact with Siva protein , though the functional significance of this interaction requires further investigation.

These interactions can be studied using various experimental approaches:

Understanding these protein-protein interactions provides insights into PXMP2's role in peroxisomal biogenesis, maintenance, and metabolite transport functions .

What is the impact of PXMP2 mutations on peroxisomal metabolism?

Mutations in PXMP2 significantly affect peroxisomal function, particularly related to metabolite transport:

• Altered membrane permeability: Since PXMP2 is involved in pore-forming activity, mutations affect the permeability of the peroxisomal membrane to various solutes .

• Metabolic consequences: In Pxmp2−/− mice, increased levels of uric acid in blood and decreased allantoin excretion have been observed, suggesting impaired transport or metabolism of these compounds .

• Partial functional redundancy: Disruption of the PXMP2 gene leads to partial (not complete) restriction of peroxisomal membrane permeability, indicating that PXMP2 is one of several proteins involved in this function .

• Normal enzymatic activity: Despite metabolic alterations, the "total" urate oxidase activity remains unchanged in Pxmp2−/− mice, suggesting that the effects are primarily on transport rather than enzymatic function .

• Disease associations: PXMP2 has been linked to conditions including Acatalasemia and Peroxisomal Biogenesis Disorder , though the precise mechanisms require further research.

These findings highlight PXMP2's importance in peroxisomal membrane function and metabolite transport, with mutations primarily affecting transport processes rather than enzymatic activities within peroxisomes .

What are the optimal protocols for detecting PXMP2 via Western blot?

For optimal detection of PXMP2 via Western blot, the following protocol parameters are recommended:

• Sample preparation:

  • Preferred tissues: Liver, kidney, or heart tissue (where PXMP2 is highly expressed)

  • Positive controls: Rat or mouse liver tissue

  • Sample amount: 20-50 μg total protein per lane

• Antibody conditions:

  • Primary antibody dilution: 1:500-1:1000

  • Incubation: Overnight at 4°C

  • Expected result: Discrete band at approximately 22 kDa

• Troubleshooting guidance:

  • If signal is weak: Increase protein loading or antibody concentration

  • If multiple bands appear: Optimize blocking conditions or try a different antibody

  • If no signal: Verify sample preparation and antibody activity

When selecting PXMP2 antibodies for Western blotting, those targeting amino acids 40-68 from the central region of human PXMP2 have demonstrated good specificity .

What are the best practices for PXMP2 immunohistochemistry?

For optimal PXMP2 detection in immunohistochemistry (IHC), specific protocols are recommended:

• Antigen retrieval methods:

  • Primary recommendation: TE buffer at pH 9.0

  • Alternative method: Citrate buffer at pH 6.0

• Antibody parameters:

  • Recommended dilution range: 1:50-1:500

  • Optimal tissues: Human, mouse, or rat liver tissue

• Controls:

  • Positive control: Liver tissue shows strong endogenous PXMP2 expression

  • Negative control: Omission of primary antibody or use of tissue from PXMP2 knockout models

• Validation data:

  • Published reactivity has been confirmed in human, mouse, and rat samples

  • Strongest signals typically observed in liver, kidney, and heart tissues, consistent with known expression patterns

These protocols should be optimized for each specific antibody and experimental system to achieve optimal results.

How should researchers validate the specificity of PXMP2 antibodies?

Thorough validation of PXMP2 antibodies is essential for reliable experimental results:

• Western Blot confirmation:

  • Verify a single band at the expected molecular weight (22 kDa)

  • Compare against positive controls (liver tissue recommended)

  • Test in multiple species if cross-reactivity is claimed (human, mouse, rat)

• Knockout/knockdown controls:

  • Compare signal between wild-type and PXMP2 knockout or knockdown samples

  • Signal should be absent or significantly reduced in knockout/knockdown samples

• Peptide competition assay:

  • Pre-incubate antibody with the immunizing peptide

  • This should eliminate or significantly reduce specific signal

• Epitope verification:

  • Common PXMP2 antibodies target epitopes in either:

    • Amino acids 40-68 from the central region

    • Amino acids 126-184 (immunogen sequence: FLIMNFLEG KDASAFAAKM RGGFWPALRM NWRVWTPLQF ININYVPLKF RVLFANLAAL)

• Tissue expression pattern:

  • Verify stronger signal in tissues known to express high levels of PXMP2 (liver, kidney, heart)

  • Pattern should match known expression profiles from transcriptomic data

These validation steps ensure that experimental results accurately reflect PXMP2 biology rather than non-specific antibody binding.

What controls should be included when studying PXMP2 in knockout models?

When studying PXMP2 in knockout or knockdown models, comprehensive controls are essential:

• Genetic controls:

  • Wild-type (WT) controls: Same genetic background as the knockout but with functional PXMP2

  • Heterozygous controls: To assess gene dosage effects

  • Non-targeting knockdown controls: For RNAi or CRISPR experiments

• Validation controls:

  • Genomic verification: PCR confirmation of gene deletion

  • Protein verification: Western blot to confirm protein absence using validated antibodies

  • Functional verification: Peroxisomal membrane permeability assays

• Metabolic assessment:

  • Measure uric acid and allantoin levels

  • Assess peroxisomal enzyme activities to determine if substrate access is affected

  • Monitor potential compensatory changes in other peroxisomal proteins

• Rescue experiments:

  • Re-expression of PXMP2 in knockout cells should restore the wild-type phenotype

  • This confirms that observed effects are specifically due to PXMP2 deficiency

Research with PXMP2 knockout models has provided valuable insights into its role in facilitating metabolite transport across the peroxisomal membrane, particularly by showing partial restriction of peroxisomal membrane permeability to solutes both in vitro and in vivo .

How can researchers optimize PXMP2 antibody use in flow cytometry?

Flow cytometry with PXMP2 antibodies requires specific considerations due to its subcellular localization:

• Cell preparation:

  • Permeabilization is essential (PXMP2 is an intracellular peroxisomal membrane protein)

  • Recommended permeabilization agents: 0.1% saponin or 0.1% Triton X-100

  • Fixation with 4% paraformaldehyde prior to permeabilization

• Antibody selection:

  • Use antibodies specifically validated for flow cytometry

  • Available conjugated formats include FITC, PE, APC, and biotin

  • Recommended dilutions: 1:10-1:50 for flow cytometry applications

• Essential controls:

  • Isotype control: Establishes background fluorescence

  • Negative control: Cell lines with low PXMP2 expression or PXMP2 knockdown cells

  • Positive control: Cell lines with high peroxisome content (e.g., hepatocytes)

• Analysis considerations:

  • Due to the intracellular nature, expect a shift in population rather than distinct positive/negative populations

  • Can be used to quantify changes in PXMP2 expression levels under different experimental conditions

  • May be combined with other peroxisomal markers for co-expression analysis

These guidelines should help researchers effectively utilize PXMP2 antibodies in flow cytometry applications for peroxisomal biology studies .